If Depression Persists Despite Treatment, Another Path to Relief Still Exists
If you've tried antidepressants, therapy, or other treatments without meaningful relief, you may qualify for Spravato® (esketamine) — an FDA-approved treatment for adults with treatment-resistant depression.
Rediscover hope through a comprehensive, physician-supervised program designed to help when traditional treatments have fallen short.
UNDERSTANDING YOUR EXPERIENCE
We don't see you as someone who has failed. We see you as someone who deserves a different kind of answer.
You Are Not Failing Treatment.
Treatment May Be Failing You.
Living with depression can feel exhausting. You may have tried multiple medications. You may have spent years searching for answers. You may look fine on the outside while silently struggling every day.
If you've been told to "just keep trying" but continue to feel trapped by depression, you're not alone. Treatment-resistant depression affects millions of people and can make even the simplest tasks feel overwhelming.
At NYC Traumatic Brain Injury & Memory Center, we provide advanced therapies specifically designed for patients who have not achieved adequate improvement with traditional approaches.
When Traditional Treatments Aren't Enough
1 in 3
FDA
Weeks
Supervised
Up to one-third of patients with depression do not achieve adequate improvement after trying multiple antidepressants.
Spravato® is FDA-approved specifically for treatment-resistant depression.
Many eligible patients report improvements within weeks rather than months.
Treatment is performed in a comfortable medical environment under direct supervision.
